Source MS Society:
Professor Alastair Compston has been awarded the first ever ‘Richard and Mary Cave Award for Services to People with multiple sclerosis’.
Professor Compston’s commitment and perseverance from the early 1990s led to the development of Lemtrada (alemtuzumab) – one of the most effective first line treatments ever approved for MS. For some people, using the drug has meant they’ve been able to live symptom free for up to ten years. Read on.